Jun Zhu
Fortuna: 14 M $ al 31/05/2026
Fortuna: 14 M $ al 31/05/2026
Jun Zhu is currently the Chief Executive Officer & Executive Director at Shanghai Henlius Biotech, Inc. He started this position in 2021.
Dr. Zhu completed his undergraduate degree at Fudan University.
He also holds an MBA from Cheung Kong Graduate School of Business, which he obtained in 2018.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 04/02/2026 | 800.000 ( 0,22 % ) | 7 M $ | 31/05/2026 | |
| 21/07/2025 | 800.000 ( 0,23 % ) | 7 M $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| SHANGHAI HENLIUS BIOTECH, INC. | Director Ejecutivo | 17/07/2023 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
Fudan University
Fudan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cheung Kong Graduate School of Business
Cheung Kong Graduate School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Shanghai Henlius Biotech, Inc.
Shanghai Henlius Biotech, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures biopharmaceutical products | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.